GH Research (FRA:1KA) Tariff Resilience Score: 6/10 (As of Jul. 05, 2026)


FRA:1KA GH Research PLC FRA:1KA
35 GF Score
Price €23.20
! 2 Warning Signs
View Full Analysis

What is GH Research Tariff Resilience Score?

GH Research FRA:1KA +1.75% 35 Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus rates FRA:1KA with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 1,369 Biotechnology companies, GH Research ranks better than 75.97% on this metric.

GH Research has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

GH Research has GH Research, a biotech firm, may face tariffs on imported research materials. While it has some pricing power, its reliance on specialized suppliers could pose risks if tariffs increase.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes GH Research might have Average Resilient.

GH Research  (FRA:1KA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

GH Research Tariff Resilience Score Related Terms

FRA:1KA vs ATAI, RAPP, NUVB: Tariff Resilience Score Comparison

For the Biotechnology subindustry, GH Research's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GH Research Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GH Research's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where GH Research's Tariff Resilience Score falls into.


FRA:1KA
35GF Score
GH Research PLC FRA:1KA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
GH Research (FRA:1KA) has a Tariff Resilience Score of 6 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, GH Research ranks #329 out of 1369 companies in the Biotechnology industry, placing it in the top 24%.
Is GH Research's Tariff Resilience Score too high?
GH Research's current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. GH Research's value of 6 is 50% above this industry median. Based on the distribution chart, GH Research ranks #329 out of 1369 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, GH Research has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does GH Research's Tariff Resilience Score compare to ATAI and RAPP?
According to the Biotechnology industry distribution chart, GH Research ranks #329 out of 1369 companies for Tariff Resilience Score. This places GH Research in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. GH Research's value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GH Research's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GH Research's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GH Research stock overvalued right now?
GH Research (FRA:1KA) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. GH Research's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For GH Research (FRA:1KA), the current Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GH Research Business Description

Other Exchanges GHRS:USA
Address Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
35GF Score

Get the complete analysis for FRA:1KA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.20
Price